Titre : Syndrome uvéo-méningo-encéphalique

Syndrome uvéo-méningo-encéphalique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Visual Field Tests
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Syndrome uvéo-méningo-encéphalique : Questions médicales les plus fréquentes", "headline": "Syndrome uvéo-méningo-encéphalique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Syndrome uvéo-méningo-encéphalique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-18", "dateModified": "2025-03-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Syndrome uvéo-méningo-encéphalique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies auto-immunes du système nerveux", "url": "https://questionsmedicales.fr/mesh/D020274", "about": { "@type": "MedicalCondition", "name": "Maladies auto-immunes du système nerveux", "code": { "@type": "MedicalCode", "code": "D020274", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.111.258" } } }, "about": { "@type": "MedicalCondition", "name": "Syndrome uvéo-méningo-encéphalique", "alternateName": "Uveomeningoencephalitic Syndrome", "code": { "@type": "MedicalCode", "code": "D014607", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Leen Alblaihed", "url": "https://questionsmedicales.fr/author/Leen%20Alblaihed", "affiliation": { "@type": "Organization", "name": "Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA. Electronic address: https://twitter.com/LeenAlblaihed." } }, { "@type": "Person", "name": "Maite Anna Huis In 't Veld", "url": "https://questionsmedicales.fr/author/Maite%20Anna%20Huis%20In%20%27t%20Veld", "affiliation": { "@type": "Organization", "name": "Department of Emergency Medicine, Elisabeth TweeSteden Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, the Netherlands; Department of Emergency Medicine, University of Maryland School of Medicine, MD, USA. Electronic address: m.huisintveld@etz.nl." } }, { "@type": "Person", "name": "Yehuda Shoenfeld", "url": "https://questionsmedicales.fr/author/Yehuda%20Shoenfeld", "affiliation": { "@type": "Organization", "name": "Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer 5265601, Ramat-Gan; Reichmann University, Herzliya, Israel." } }, { "@type": "Person", "name": "Rosanna Fulchiero", "url": "https://questionsmedicales.fr/author/Rosanna%20Fulchiero", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA." } }, { "@type": "Person", "name": "Patricia Seo-Mayer", "url": "https://questionsmedicales.fr/author/Patricia%20Seo-Mayer", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA; Division of Nephrology and Hypertension, Pediatric Specialists of Virginia, 3023 Hamaker Court, Suite 600, Fairfax, VA 22031, USA; Virginia Commonwealth School of Medicine, Richmond, VA, USA. Electronic address: Pseo-mayer@psvcare.org." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The number of examinations required for the accurate prediction of the progression of the central 10-degree visual field test in glaucoma.", "datePublished": "2022-11-07", "url": "https://questionsmedicales.fr/article/36344722", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-23604-z" } }, { "@type": "ScholarlyArticle", "name": "Assessment of visual field progression in glaucoma.", "datePublished": "2022-11-15", "url": "https://questionsmedicales.fr/article/36378107", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/ICU.0000000000000932" } }, { "@type": "ScholarlyArticle", "name": "Visual Field Defect Patterns Associated With Lesions of the Retrochiasmal Visual Pathway.", "datePublished": "2022-06-14", "url": "https://questionsmedicales.fr/article/36166759", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/WNO.0000000000001601" } }, { "@type": "ScholarlyArticle", "name": "Association of superficial macular vessel density with visual field progression in open-angle glaucoma with central visual field damage.", "datePublished": "2023-05-03", "url": "https://questionsmedicales.fr/article/37137927", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-34000-6" } }, { "@type": "ScholarlyArticle", "name": "Visual fields in glaucoma: Where are we now?", "datePublished": "2023-02-16", "url": "https://questionsmedicales.fr/article/36751125", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ceo.14210" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Maladies auto-immunes", "item": "https://questionsmedicales.fr/mesh/D001327" }, { "@type": "ListItem", "position": 4, "name": "Maladies auto-immunes du système nerveux", "item": "https://questionsmedicales.fr/mesh/D020274" }, { "@type": "ListItem", "position": 5, "name": "Syndrome uvéo-méningo-encéphalique", "item": "https://questionsmedicales.fr/mesh/D014607" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Syndrome uvéo-méningo-encéphalique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Syndrome uvéo-méningo-encéphalique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Syndrome uvéo-méningo-encéphalique", "description": "Comment diagnostiquer le syndrome uvéo-méningo-encéphalique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent ce syndrome ?\nLe syndrome peut-il être confondu avec d'autres maladies ?\nQuelle est l'importance de l'analyse du LCR ?", "url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Syndrome uvéo-méningo-encéphalique", "description": "Quels sont les symptômes principaux du syndrome ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir de la fièvre avec ce syndrome ?\nLes symptômes sont-ils toujours présents ?", "url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Syndrome uvéo-méningo-encéphalique", "description": "Comment prévenir le syndrome uvéo-méningo-encéphalique ?\nLes vaccinations sont-elles efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nY a-t-il des groupes à risque ?\nLes voyages augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Syndrome uvéo-méningo-encéphalique", "description": "Quel est le traitement principal du syndrome ?\nLes antibiotiques sont-ils nécessaires ?\nComment gérer les symptômes neurologiques ?\nY a-t-il des traitements préventifs ?\nQuelle est la durée du traitement ?", "url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Syndrome uvéo-méningo-encéphalique", "description": "Quelles sont les complications possibles ?\nLe syndrome peut-il entraîner des séquelles à long terme ?\nY a-t-il un risque de récidive ?\nComment surveiller les complications ?\nLes complications peuvent-elles être évitées ?", "url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Syndrome uvéo-méningo-encéphalique", "description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'environnement peut-il affecter le risque ?\nLes voyages à l'étranger augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Visual+Field+Tests&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le syndrome uvéo-méningo-encéphalique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique, l'imagerie cérébrale et des analyses de liquide céphalorachidien." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des IRM, des tomodensitométries et des analyses de sang et de LCR sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent ce syndrome ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des maux de tête, des troubles visuels et des convulsions peuvent indiquer le syndrome." } }, { "@type": "Question", "name": "Le syndrome peut-il être confondu avec d'autres maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec d'autres infections neurologiques comme la méningite bactérienne." } }, { "@type": "Question", "name": "Quelle est l'importance de l'analyse du LCR ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse du LCR permet de détecter des signes d'inflammation et d'infection, cruciaux pour le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux du syndrome ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des troubles de la vision, et des signes neurologiques." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des convulsions, des troubles de la conscience et des déficits neurologiques peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la gravité de l'infection." } }, { "@type": "Question", "name": "Peut-on avoir de la fièvre avec ce syndrome ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fièvre est un symptôme fréquent, souvent accompagnée de signes d'inflammation." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours présents ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains patients peuvent présenter des symptômes légers ou intermittents." } }, { "@type": "Question", "name": "Comment prévenir le syndrome uvéo-méningo-encéphalique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par la vaccination contre les infections virales et l'hygiène personnelle." } }, { "@type": "Question", "name": "Les vaccinations sont-elles efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations peuvent réduire le risque d'infections virales associées au syndrome." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter le contact avec des personnes malades sont recommandés." } }, { "@type": "Question", "name": "Y a-t-il des groupes à risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes immunodéprimées et celles vivant dans des zones d'épidémie sont à risque accru." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones où des infections virales sont endémiques peut augmenter le risque." } }, { "@type": "Question", "name": "Quel est le traitement principal du syndrome ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal inclut des antiviraux, des corticostéroïdes et des soins de soutien." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques ne sont pas efficaces contre les infections virales, mais peuvent être utilisés si une infection bactérienne est suspectée." } }, { "@type": "Question", "name": "Comment gérer les symptômes neurologiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes neurologiques peuvent être gérés par des anticonvulsivants et des soins neurologiques spécialisés." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de traitements préventifs spécifiques pour ce syndrome." } }, { "@type": "Question", "name": "Quelle est la durée du traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement varie selon la gravité de l'infection et la réponse au traitement, souvent plusieurs semaines." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des séquelles neurologiques, des troubles de la vision et des crises épileptiques." } }, { "@type": "Question", "name": "Le syndrome peut-il entraîner des séquelles à long terme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent développer des séquelles neurologiques à long terme après le traitement." } }, { "@type": "Question", "name": "Y a-t-il un risque de récidive ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le risque de récidive dépend de la cause sous-jacente et de l'état immunitaire du patient." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier avec des examens neurologiques et des imageries est essentiel pour surveiller les complications." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par un traitement précoce et approprié de l'infection." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'immunodépression, les infections virales antérieures et l'exposition à des vecteurs." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées sont souvent plus à risque de développer ce syndrome." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents d'infections neurologiques augmentent le risque de développer ce syndrome." } }, { "@type": "Question", "name": "L'environnement peut-il affecter le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, vivre dans des zones où des infections virales sont fréquentes augmente le risque." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des régions où des épidémies d'infections virales sont présentes peut augmenter le risque." } } ] } ] }

Sources (10000 au total)

Assessment of visual field progression in glaucoma.

Perimetry plays an important role in the diagnosis and management of glaucoma. This article discusses the assessment of visual field progression in patients with glaucoma.... Selecting the best visual field test strategy and establishing a baseline of visual fields will assist clinicians in the detection of glaucomatous progression. Repeat testing serves to confirm or refu... Many treated patients with glaucoma will experience visual field progression. Optimal utilization of visual field testing strategy and analytical software can help clinicians identify patients with gl...

Visual Field Defect Patterns Associated With Lesions of the Retrochiasmal Visual Pathway.

Perimetry is widely used in the localization of retrochiasmal visual pathway lesions. Although macular sparing, homonymous paracentral scotomas, and quadrantanopias are regarded as features of posteri... Retrospective record review conducted in a single, academic, medical center using an electronic search engine with the terms ""homonymous hemianopia," "optic tract," "temporal lobectomy," "visual fiel... From an original cohort of 256 cases, only 83 had MRI-defined lesions that were limited to particular retrochiasmal segments and had visual field defect patterns that allegedly permitted localization ... In correlating discrete MRI-defined retrochiasmal lesions with visual field defect patterns identified on static perimetry, this study showed that macular sparing, homonymous paracentral scotomas, and...

Humphrey visual field made easy for residents.

Visual field testing is an indispensable part of the assessment of glaucoma. Of paramount importance to both the practitioner and the perimetrist is the guidance on how to conduct the test to get the ... To simplify the basics of understanding single-field analysis of visual field tests by using the Humphrey perimeter.... The general principle and a brief overview of how the Humphrey visual field is conducted and the approach to interpreting the results of single field analysis in an easy-to-understand manner are prese... This educational video is an attempt to simplify the interpretation of Humphrey visual field single-field analysis with illustrations and video clips that would be useful to practicing ophthalmologist... https://youtu.be/x8iZLDR4XdY....

Foveal avascular zone vessel density is associated with visual field progression in early-stage glaucoma eyes with central visual field damage.

We investigated the relationship between foveal avascular zone (FAZ)-related parameters, assessed by optical coherence tomography angiography (OCT-A), and visual field (VF) progression in early-stage ...

Five-Year Visual Field Outcomes of the HORIZON Trial.

To compare visual field (VF) progression between glaucoma patients receiving cataract surgery alone (CS) or with a Hydrus microstent (CS-HMS).... Post hoc analysis of VF data from the HORIZON multicenter randomized controlled trial.... A total of 556 patients with glaucoma and cataract were randomized 2:1 to either CS-HMS (369) or CS (187) and followed up for 5 years. VF was performed at 6 months and then every year after surgery. W... Data from 352 eyes in the CS-HMS arm and 165 in the CS arm were analyzed (2966 VFs). The mean RoP was -0.26 dB/y (95% credible interval -0.36, -0.16) for CS-HMS and -0.49 dB/y (95% credible interval -... CS-HMS has a significant effect on VF preservation in glaucoma patients compared with CS alone, reducing the proportion of fast progressors....

A Consensus Statement on the Terminology for Automated Visual Field Abnormalities.

A multitude of terms have been used to describe automated visual field abnormalities. To date, there is no universally accepted system of definitions or guidelines. Variability among clinicians create... In phase one of the study, all neuro-ophthalmologists in Israel were asked to complete a survey in which they described the abnormalities in 10 selected automated visual field tests. In phase 2 of the... Twenty-six neuro-ophthalmologists participated in the initial survey. On average, there were 7.5 unique descriptions for each of the visual fields (SD 3.17), a description of only the location in 24.6... The study confirmed a great degree of variability in the use of terminology to describe automated visual field abnormalities. The creation of a consensus statement was associated with improved use of ...